Rocket Lab USA, Inc (Nasdaq: RKLB), a leading launch and space systems company, today released its Impact report, highlighting Rocket Lab’s commitment to make it faster, easier, and more affordable to ...
Zai Lab (NASDAQ:ZLAB) reported positive topline data from a Phase 3 study in China for KarXT in the treatment of schizophrenia. The FDA approved KarXT for schizophrenia in September. The drug will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback